Try our Advanced Search for more refined results
Life Sciences - May, 2022
314 articles
- FCA Split Has High Court Momentum Despite DOJ's Critique
- Ex-CEO Facing Indictment, SEC Suit Over COVID-19 Test Kits
- 11th Circ. Won't Revive Medical Co.'s Coverage Suit
- Regeneron Rips Amgen's 'Bundling Scheme' Amid IP Feud
- Skinny Labels' Future May Hinge On Teva Petitioning Justices
- 2 FCA Settlements Highlight Gov't Cyber Liability Focus
- CRISPR Nobel Prize Winners Beat European Patent Challenge
- Catching Up With Delaware's Chancery Court
- 2 Firms Guide Cardio Diagnostics' $175M SPAC Merger
- Iowa Justices Affirm Possession Conviction For Pot Patient
- Cannabis Moneyball Has Begun, And The Game Is Heating Up
- Law360 Names 2022's Top Attorneys Under 40
- Opioid Judge Raiding Settlements For Atty Fees, 6th Circ. Told
- Texas High Court To Weigh In On Cotton Crop Pesticide Fight
- USTR Again Extends China Tariff Reprieve For COVID-19 Gear
- Cannabis Bill Roundup: New Legalization Proposal In NC
- Janssen Launches Patent Suit Over Prostate Cancer Drug
- Justices Should Give Feds' Roundup Amicus Little Weight
- Biopharma Co.'s Lies Caused Investor Losses, Suit Claims
- FDA Sends Warning Letters To Cos. Selling CBD Animal Drugs
- Hirshfeld's Arthrex Clearance Empowers Interim Leaders
- Teva And Cephalon's Marketing Ignored Plea Deal, Judge Told
- Ex-Theranos Exec's Fraud Trial Delayed Until June 7
- Drink Co. Touted Health Claims To Skirt Calif. Fees, Jury Told
- J&J Aims To Block Counsel Deposition In Ex-Exec's Bias Suit
- Cardinal Investors Reach $124M Settlement In Opioid Suit
- 11th Circ. Won't Revive Optometry Clinic's Virus Coverage Suit
- No Toss For Del. Suit Targeting $11.6B Sanofi-Bioverativ Deal
- Startup Wants Illumina Trade Secret Suit Tossed
- ABA Isn't Giving Up On Diversity Efforts By Ending CLE Rule
- 3rd Circ. Won't Undo Investors' Win Over 'True Fraudster'
- J&J Unit Hit With BIPA Suit Over Skin Care App's Face Scans
- Nuclear Med JV Looks To Keep Award Enforcement In NY
- 'Profound' Stakes In Drug Discount Suit, Eli Lilly Tells 7th Circ.
- PTAB Ruling Shows Need To Split Terminal Disclaimer
- Pharmacy Owner Gets 4 Years For $7.2M Rebate Fraud
- Sens. Urge FDA, USPTO To Cooperate On Generic Drugs
- Monsanto Knew Of PCBs' Dangers, Jury Hears In Latest Trial
- Walmart Can't Escape Suit Over Crash That Killed Girl Scouts
- Generic Distributors Slip Indirect Reseller Price-Fixing Claims
- Arnold & Porter Stuck In Sanctions Scuffle Despite Endo's Exit
- SF Opioid Judge Is Told Cos. Put Profits First In Marketing
- Witness Travel 'Not My Problem,' Judge Tells Drink Co. Attys
- How To Protect Health Care Trade Secrets With Covenants
- Feds Tell Justices Not To Wade Into Anthem Drug Price Case
- FDA Found 'Egregious' Conditions At Abbott Baby Food Plant
- Lateral Candidate Screening Steps To Prevent Bad Behavior
- Using Bayh-Dole For Cancer Drug March-In Rights Is Wrong
- Nipro Corp. Pays $21M After Avoiding ICC Arbitration Award
- Pfizer To Sell Low-Cost COVID Vaccine, Drugs To Poor Nations
- Pharma Co. Data Breach Exposed 75K Patients' Info, Suit Says
- Atty Wants SEC Penalties Delayed Amid Jury Polling Kerfuffle
- Del. Justices Take 'Critical' Look At Zimmer Biomet Suit
- Masimo Says Stay Is Over In Apple Patent Fight
- Teva, Allergan Strike $161M Deal With W.Va. AG In Opioid Case
- FCA Pleading Split Is Finally Kaput, DOJ Tells High Court
- Ex-Anda Chief OK'd Unlimited Opioid Supplies, Judge Hears
- FTC Launches Inquiry Into Infant Formula Shortage
- Fed. Circ. Told PTAB Flouted AIA In Gene-Editing Interference
- Investors' Attys Seek $29M Cut Of Novo Nordisk Deal
- CSL Plasma Inks $9.9M BIPA Deal With Blood Plasma Donors
- Pay Consultant Traded On Client's Sanofi Intel, Feds Say
- Justices Urged Not To Review $87M Monsanto Roundup Loss
- HSR Statistics Show Increasing Scrutiny Of Health Care M&A
- Committee Pros Approved In J&J Talc Unit's Ch. 11 Case
- A Look At The Legal Profession Since Murder Of George Floyd
- Fed. Circ. Won't Breathe New Life In Cornell's Enzyme Patent
- Week In Bankruptcy: Dioceses Settle; Wind-Downs Reined In?
- Mylan Hit With Infringement Suit Over MS Generic Drug
- Fed. Circ. Acne Drug IP Holding Clarifies Obviousness Factors
- 2 Firms Will Lead Northwest Biotherapeutics Pay Suit In Del.
- Joint Juice Is 'Snake Oil,' Not Health Aid, Jurors Hear
- Moderna Wants Claims In COVID-19 Vax Patent Suit Tossed
- DEA Draws Judge's Ire In Calif. Opioid Trial
- Judge Skeptically Probes Fate Of FDA's Cigar Regulation
- Ethicon Loses Fed. Circ. Bid To Revive Surgical Tool Patent
- Novartis Owes Royalties, Bristol-Myers Squibb Says
- Mallinckrodt Calls Shareholder Ch. 11 Stay Bid Untimely
- Vanda Fights FDA's Refusal To Fast-Track Gastro Drug Review
- Monsanto Urges High Court To Take Up $25M Roundup Verdict
- NY Ruling Correctly Deems Legal Finance Docs Irrelevant
- Addressing Low Response Rates In Expert Surveys
- Avanir Hit With Suit Over Alleged Nuedexta Kickback Scheme
- McCarter & English Enters Midwest With New Indiana Office
- Catching Up With Delaware's Chancery Court
- Balwani Trial Goes On, Despite Juror's Positive COVID-19 Test
- Ex-Claims Court Chief Chides Warren's Drug Pricing Plan
- FDA Won't Totally Ban Phthalates From Food Packaging
- Gilead Loses Patent Case Over Lexiscan Generic
- First Wave Bio Investors Sue In Del. For AzurRx Merger Money
- Fed. Circ. Says Child Due Compensation For Vaccine Injuries
- Ill. BCBS Hit With Fertility Treatment Bias Claims
- Chancery Warns EpicentRx About 'Flouted' Case Deadlines
- Drugmakers Say Pa. AG Not Producing Generic-Drug Docs
- Health Hires: Pharvaris, VistaGen, Dykema
- New Suit Targets FAA's OK Of Ga. Rocket Launch Site
- Holmes' Sealed Docs Might Sway Balwani Jury, Judge Says
- 7th Circ. Tore 'Gaping Hole' In FCA, Grassley Tells High Court
- SF Fire Dept. Treats 7 Opioid Overdoses Daily, Judge Told
- Del. Judge Dumps Suit Targeting DuPont Spinoff's Enviro Bills
- Ill. Court Reverses J&J Contempt In Talc Cancer Case
- IP Forecast: Crocs Takes Look-Alike Shoe Fight To ITC
- FDA Defeats Ban On Warning Of Veterinary Pharmacy's Drugs
- Epstein Becker Taps Wilentz Cannabis, Health Care Pro
- Fed. Circ. Upholds PTAB Ax Of J&J Unit's Surgical Patent
- Justices Told Fraud Tainted Vascepa Patent Invalidations
- Valisure Can't Get Fees For Quashed Subpoena In Zantac MDL
- 3rd Circ. Won't Revive Federal Claim On Pharma Accreditation
- WTO Talks On Vaccine Patents Falter As Pandemic Surges
- Procopio Adds Life Sciences IP Attorney From Snell & Wilmer
- 11th Circ. Ban On Service Awards May Inhibit Class Actions
- Overcommunicate With Your Summer Associates This Year
- ERISA Ruling Shows Lax Enrollment Practices Can Be Costly
- Medtronic Worker Can't Escape $1.3M Claim In Poaching Suit
- Even With Pandemic, Patent Suit Filings Held Steady In 2021
- 7th Circ. Throws Out $11M Fee Award For Bernstein Litowitz
- Balwani Shut Down $96M Investor's Due Diligence, Jury Told
- Many SF Walgreens Opioid Scripts Had Red Flags, Judge Told
- Hemp Biz Group Urges FDA Action On CBD After New Study
- AbbVie Execs Put 'Profits Over Compliance,' Investor Says
- 'Pharma Bro' Shkreli Released From Federal Prison Early
- IQVIA Holds On To Key Defense In Trade Secrets Spat
- Mallinckrodt Noteholders Say They're Owed $94M For Default
- The State Of Intradistrict Venue Transfer In West Texas
- Judge Invalidates Medicaid 'Accumulator Adjustment Rule'
- Purdue Ch. 11 Bonus Plan Gets Court OK, CEO's Delayed
- Medical Device Co. Sues Unit Founder For Starting Competitor
- Docs Urge 1st Circ. To Revive J&J Hip Replacement FCA Suit
- Novartis' DQ Bid Sinks In Gilenya Row
- What FDA Warning Letters Signal About Delta-8 Enforcement
- Biotech Research Center Escapes Engineer's Paid Leave Suit
- Nev. Case Highlights Settlement Authority Dilemmas For Cos.
- Teva Unit Marketed Opioid For Off-Label Uses, Judge Hears
- Ohio Counties Put On Show In Opioid Damages Trial
- The Week In Bankruptcy: Purdue Bonus, PR Pension Appeal
- Neb. Medical Pot Campaign Sues Over 'Unconstitutional' Rule
- FDA Clears COVID-19 Boosters For 5-11 Age Group
- Vaping Cos. Say FDA Changed Rules On Flavored Products
- Hospitals Rally Around Drug Discounts In Pharma Fight
- USPTO Asks Fed. Circ. Not To Rule On Hirshfeld's Power
- Sick Juror Delays Ex-Theranos Exec's Criminal Fraud Trial
- Key Rulings And Cases As COVID Claimed 1M American Lives
- Atty Asks New Judge For SEC Trial Redo After Polling Blunder
- Bristows Boosts Life Sciences Team With Partner Promotion
- Yale New Haven Health Atty Joins Dana-Farber As GC
- Judge Says Cos. Don't Have To Cover Gender Transition Care
- FCA Intrigue Intensifies As High Court Again Invites DOJ Input
- Doctors' Opioid Data Kept From Walgreens Stores, Judge Told
- Counties Bungled $875M Ask After Opioid Trial, Judge Told
- Hemp Equipment Seller's Counterclaims Fail, Court Told
- Gilstrap Won't Pause $42M Seagen Drug Patent Row For PTAB
- Finding Uninjured Consumers In Drug Antitrust Class Actions
- High Court Won't Hear 3M's Appeal In Surgical Blanket Case
- Catching Up With Delaware's Chancery Court
- Medical Testing Co. Sues For More Time To Pay $4M Loan
- Pharma Products' Uncertain Path To Patient Assistance
- Insys Founder Says Looming Opioid Ruling Boosts Appeal
- Walgreens Deal Spurred Quick Theranos Investment, Jury Told
- Pharmaceutical Co. Sued Over Recalled Thyroid Medication
- Ex-Lab Exec Wants FCA Suit Axed Over 'Blood Money' Book
- States Say Purdue CEO Should Answer For Opioid Crisis Role
- Drugmaker Wants $950M Vaccine Trade Secrets Suit Tossed
- Texas v. Pandemic: How The Lone Star State Litigated COVID
- 2 Approaches To NY Choice Of Law In Employment Contracts
- Ohio Pharmacy Board Subpoena Case Returned To Trial Court
- The Fastest Federal Trial Courts: A Look At Virginia, Florida
- Womble Bond Expands IP Practice In Texas, NC
- Consulting Firm Wants Out Of Ark. Pot Licensing Suit
- 'Measly' Opioid Fine Invites BigLaw Defiance, NY AG Warns
- Walgreens' Priority Was Filling Drug Orders Fast, Judge Told
- Air Force Wants To Toss Vax Mandate Challenge
- ABA Calls For Better Security For High Court, Federal Bench
- IP Forecast: 9th Circ. To Hear A Tale Of Two Punchbowls
- 3 Takeaways As China Rolls Out Its Version Of ANDA Disputes
- Cannabis Co. Nabs Atty Fees In CBD Cream Patent Row
- 9th Circ. Hunts For Rationale To Cut $925M ViSalus TCPA Loss
- Auctioneer Says Cancer Charity To Blame For Embezzlement
- French SPAC Raises $156M To Support Drug Development
- Fed. Circ. Says LabCorp Missed Chance To Move Patent Row
- TGIF: Why Juries Love To Start The Weekend With A Verdict
- Synthetic Nicotine Industry Could Be Set To Evaporate
- Bid Protest Spotlight: Late-Is-Late, Party Interest, Timeliness
- Pension Fund Asks 11th Circ. To Revive Suit Against MiMedx
- Tips For Evaluating Machine Learning For Contracts Review
- Conspiracy Caused Insulin Price Spike, Arkansas Says
- Walgreens' Opioid Orders Like A 'Time Bomb,' Judge Told
- W.Va. Opioid Defense Expert Testifies Death Data Are Suspect
- Settlements Worth $86M OK'd In Drug Price-Fixing MDL
- DOJ Ups Marshal Security For Justices Amid Roe Protests
- Balwani Invoked Lawyers To Cow Wavering Investor, Jury Told
- Ex-Sleep Number Execs Can't File For Patents, 8th Circ. Says
- Fla. Court Erases $148M Punitive Damages In Smoker's Suit
- Lawmakers Say Emergent Destroyed 400M COVID Vaccines
- How Russia's Parallel Import Order May Affect Companies' IP
- Feds Settle GMO Salmon Suit Fees Issue With Enviro Groups
- SEC Slams Priest For 'Galling' New Fraud Trial Bid
- J&J Ch. 11 Talc Claimants Get Nod For 3rd Circ. Appeal
- Senate Vote To Codify Roe Abortion Protections Fails
- Why Cos. Are Betting On Cannabis Drinks Despite Legal Risks
- FDA Asks To Nix Ban On Warning Of Animal Pharmacy's Drugs
- Counsel Leadership Fight Heats Up In Pharma Pay Suit In Del.
- Doctor Who Gave Out 'Goodie Bags' Of Drugs Gets 20 Years
- Conn. Atty Says SEC Lacked Evidence For Fraud Trial Win
- Chancery Orders Biogen To Give Documents To Investor
- Opioid Jurors Detail Talks As Pharmacy Trial Gets Feisty Start
- 'Catastrophic' SF Opioid Death Toll Like AIDS Era, Judge Told
- End-Payor State Claims Stick In Generic Drug Price-Fix MDL
- Balwani Didn't Void Tests After Feds Flagged Issues, Jury Told
- Ex-Pharma CFO Indicted For Allegedly Giving Girlfriend Info
- Medtronic Shedding Intersect Unit For $1B Deal
- Full 4th Circ. To Eye $680M FCA Case Against Allergan
- Feds Ask Justices To Let $25M Monsanto Roundup Verdict Be
- Judge Vacates Pot Co. Investors' Class Certification, For Now
- Attys Urge 4th Circ. To Revisit W.Va. Law On Drug Case Ads
- Animal Health Co. Investors Nab $35M Deal Over Spinoff
- Sanitizer Co. Gets OK For Ch. 11 Loan To Destroy Products
- DC Circ. Revives Plasma Companies' Visa Policy Suit
- Gilead Slaps Rivals With Patent Suit Over HIV Drug
- Sens. Rip Biden Admin. For Cutting Them Out Of Trade Policy
- How To Efficiently Deploy Your Professional Growth Strategy
- Researchers Want DEA To Move On Pot Import Application
- Pfizer To Buy Biohaven Pharmaceuticals In $11.6B Deal
- Massive Opioid Campaign Duped Docs, Bellwether Judge Told
- 'No Legitimate Basis' For New Opioid Trial, NY AG Insists
- Surgeon Wants Patent Win Against J&J Unit Tripled To $60M
- Judge OKs $75M Deals In Contact Lens Price-Fixing Suit
- Biopharmaceutical Co. Investor Contests Director Pay In Del.
- 8th Circ. Says Insurer Flouted ERISA In Paperwork Mishap
- A 6-Step Framework For Legal Industry Professional Growth
- ITC Recommends Exclusion Order In Case Warning Of IP Theft
- Fed. Circ. Won't Block Generic Lung Drug During Appeal
- Catching Up With Delaware's Chancery Court
- Chancery Should Order Biogen To Give Up Docs, Report Says
- Seller Of Racehorse PEDs In 2020 Doping Scandal Convicted
- Why Contempt May Be Apt Punishment For High Court Leaker
- Moderna Says COVID-19 Vax Patent Suit Should Be Tossed
- Pharmacies Face Key Trial Test As Opioid MDL Intrigue Swirls
- Fed. Circ. Mulls Scope Of Eye Tech Software Injunction
- Walgreens Says Insurers Must Defend It In Opioid Cases
- Judge Ruled On Investors' Class Cert. Too Early, Pot Co. Says
- Fed. Circ. Rejects Narcan Maker's Redo Bid In Patent Suit
- After $12M Jury Win, Israeli Biz Asks Albright To Triple That
- Chancery Dismisses Suit Against Ex-Medical Pot Pharma Co.
- Judge Axes Benicar Fee Suit, Says Firm Didn't Overcharge
- Illumina Told To Pay $334M In DNA Sequencing Patent Trial
- Without Dissents, Dobbs Draft Is One-Sided Abortion Debate
- Veterinary Pharmacy Sues FDA To Block Products Warning
- Anthem Gets Spinal Device Coverage Denial Suit Tossed
- 5 Firms Steer Bausch & Lomb's Below-Range $630M IPO
- WilmerHale Brings In Gibson Dunn Technology Litigator In SF
- FDA Significantly Curtails J&J's COVID Vaccine Clearance
- 5 Law Firms Guide Centene's $2.8B Pharmacy Divestments
- IP Updates: E-Filing Grows In US; Payments OK'd For Russia
- Novartis Can't DQ Rival's Atty In Drug IP Row, Report Says
- Investors In Pot Co. Aphria Win Class Cert. In $144M Suit
- Fed. Circ. Partly Revives Another Surgical Robot IP Challenge
- Biotech Co.'s Ex-CEO Delayed In Suing Board, Court Says
- Mass. Woman Can't Revive Genzyme Injection Injury Suit
- Eligibility Law Keeps Evolving As American Axle Awaits SG
- Psychedelic Sector Can Learn From Cannabis Legal Hurdles
- Spinal Device Co. Inks $1M Midtrial Deal To End FCA Claims
- UMass Student's Graduation May End Vax Suit, 1st Circ. Hints
- Clients' Diversity Mandates For Law Firms Are Necessary
- Florida And Walgreens End Opioid Trial With $683M Deal
- J&J Says Benefit Co. Bilked Millions From Patient Drug Fund
- Balwani Can't Use Giant Spreadsheet In Theranos Defense
- Spinal Implant Co. Accused Of Doctor Kickbacks In FCA Trial
- House Lawmakers Unveil FDA Spending Package
- Chancery OKs $2.3M Deal To End Cancer Drug Disclosure Suit
- Expanded Talc Claim Committee Nixed In J&J Unit's Ch. 11
- Ex-Dean Gets 1 Year For Defrauding $651K From Student Org.
- Hemp Industry Eyes Major Changes In Next Farm Bill
- FDA Warns Cos. They're Illegally Marketing Delta-8 THC Goods
- Harvard, 10x Say Rival Co. Infringed Spatial Imaging Patents
- Del. Chancery Stays Stimwave Tech's Battle With Ex-CEO
- Even If Roe Is Dead, Abortion Suits Are Far From Over
- Chemical Co. Told To Provide Docs In Patent Row With Ecolab
- Policyholder Gains In Virus Coverage State Trial Court Suits
- Air Force Members Want Class Cert. In Ga. Vax Mandate Case
- Full Fed. Circ. Won't Eye New PTAB Forum Selection Ruling
- Pfizer Scientist Didn't OK Theranos Using Logo, Jury Hears
- Clues In Alito's Draft Suggest He's Not Reaching For Roberts
- Alito's Leaked Opinion May Be Far From Final Word On Roe
- Leak Likely To Spur Paranoia At High Court, Legal Pros Say
- WTO Releases Draft Of Controversial COVID Vaccine IP Waiver
- Dobbs Draft Could Jeopardize More Than Abortion Precedent
- 5th Circ. Told To Undo Block Of Texas Abortion Law
- IPO Lawyers See Mild Pickup In An Otherwise Cool Spring
- Week In Bankruptcy: Purdue On Defense, Becker Goes To Jail
- Biden Launches Mandatory Review Of Trump-Era China Tariffs
- Pharmacy Co. Investors Seek Final OK Of $15.5M Deal
- Amazon Pharmacy PillPack Pays $5.8M For Insulin Overbilling
- 1 Big Hurdle Blocks Senate Bid To Codify Abortion Rights
- 11th Circ. Asked To Revive Suit Over Opioid Claim Coverage
- Fox Rothschild Opens Boston Office With Mintz IP Team
- Pharma Co.'s Counsel Blasts Missed Deadlines In Del. Suit
- Leak Casts Pall On High Court Ahead Of Final Abortion Ruling
- Shook Hardy Adds Litigator To Lead New Hartford Office
- Ex-HHS Deputy GC Joins UpStream Healthcare In DC
- Wash. AG, Distributors Cut $518M Deal Ending Opioid Trial
- 5 Questions That Can Help Law Firms Win RFPs
- Have We Asked For Cannabis Legalization To Do Too Much?
- Drugmaker Loses Jurisdiction Challenge Over Royalties Suit
- Roberts Launches Probe Into Leaked Abortion Draft Opinion
- Court Says Pot Growers 'Fall So Short' In Calif. Cop RICO Suit
- ITC To Probe Drug Cos. Accused Of Using Medytox Secrets
- NHK-Fintiv Can't Be Challenged, Patent Office Tells Fed. Circ.
- Chinese Citizen Convicted Of Stealing GSK Trade Secrets
- IBF Properties Lands $150M Loan For 24 Walgreens Stores
- Juul And Altria Can't Cut Most Claims From Teen's Vaping Suit
- Catching Up With Delaware's Chancery Court
- How Law Firms Can Employ More Veterans
- Goodwin-Led Biotech Startup Launches Plans For $101M IPO
- Ex-Client Fights Buchanan Ingersoll's $1.9M Fee Lien